Skip to main content

Regions

By Jessica Hagen | 05:51 pm | November 13, 2024
The health management company will integrate Ubie's symptom checker into its platform to support patients from symptom onset through treatment.
By Anthony Vecchione | 02:38 pm | November 13, 2024
The aim of the acquisitions is to accelerate the company's involvement in two major growth areas and improve patient care.  
By HIMSS TV | 01:34 pm | November 13, 2024
Mike Relli, principal at Knight Consulting, highlights the difficulties individuals face transitioning from incarceration into public life, Medicaid's 1115 waivers and interoperability, in order to support all stakeholders in the process.   
By Jessica Hagen | 11:58 am | November 13, 2024
The Society urges collaboration between clinicians and technologists, and healthcare organizations to use the tech to assist the clinical workforce, not replace it. 
By HIMSS TV | 06:17 pm | November 12, 2024
Third-party risk management was the No. 1 weak link reported in organizations' cyberdefense strategies, says Jill Brewer, market insights lead at HIMSS. The No. 1 technology to use is AI-powered threat-detection and analytics.  
By HIMSS TV | 04:55 pm | November 12, 2024
Richard Staynings, a University of Denver professor, highlights the drawbacks and benefits of AI in patient care and precision medicine, advancing cybersecurity in healthcare, and malicious use of the technology to get past malware defenses.
By Anthony Vecchione | 04:13 pm | November 12, 2024
The alliance aims to make it easier for patients to check their coverage and connect with personalized mental health services.
By Anthony Vecchione | 02:14 pm | November 12, 2024
Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.
By Jessica Hagen | 01:25 pm | November 12, 2024
The launch comes a little over one year after digital health firm Babylon sold almost all of its U.K. assets to digital health company eMed Healthcare U.K.
By Jessica Hagen | 06:50 pm | November 11, 2024
According to Bloomberg, the brain-implant chipmaker raised $93 million in funding, increasing the startup's valuation to approximately $500 million.